Genomics-Guided Exploitation of Lipopeptide Diversity in Myxobacteria.

ACS Chem Biol

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research and Pharmaceutical Biotechnology at Saarland University, Saarland University Campus, Building E8.1, 66123 Saarbrücken, Germany.

Published: March 2017

Analysis of 122 myxobacterial genome sequences suggested 16 strains as producers of the myxochromide lipopeptide family. Detailed sequence comparison of the respective mch biosynthetic gene clusters informed a genome-mining approach, ultimately leading to the discovery and chemical characterization of four novel myxochromide core types. The myxochromide megasynthetase is subject to evolutionary diversification, resulting in considerable structural diversity of biosynthesis products. The observed differences are due to the number, type, sequence, and configuration of the incorporated amino acids. The analysis revealed molecular details on how point mutations and recombination events led to structural diversity. It also gave insights into the evolutionary scenarios that have led to the emergence of mch clusters in different strains and genera of myxobacteria.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acschembio.6b00953DOI Listing

Publication Analysis

Top Keywords

structural diversity
8
genomics-guided exploitation
4
exploitation lipopeptide
4
lipopeptide diversity
4
diversity myxobacteria
4
myxobacteria analysis
4
analysis 122
4
122 myxobacterial
4
myxobacterial genome
4
genome sequences
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!